ARTIVITY LTD

Company number 13815438 ·

Active

This analysis was written by an AI from the company's public filings. It may contain errors or omissions and is not financial or professional advice.

ARTIVITY LTD - Analysis Report

Company Number: 13815438

Analysis Date: 2025-07-29 15:05 UTC

Financial Health Assessment for ARTIVITY LTD


1. Financial Health Score: D

Explanation:
ARTIVITY LTD’s financial position has shown significant deterioration between 2022 and 2023, with a sharp decrease in net assets and a negative net current asset position in the latest year. This score reflects signs of financial distress and liquidity challenges that require immediate management attention.


2. Key Vital Signs

Metric 2023 (£) 2022 (£) Interpretation
Fixed Assets 2,891 4,178 Slight asset reduction; manageable but should be monitored.
Current Assets 1,190 12,036 Significant decline; potential cash flow issues.
Current Liabilities 2,692 3,548 Slight reduction, but still exceeds current assets.
Net Current Assets (1,082) 8,615 Negative working capital indicates liquidity stress ("symptom of distress").
Total Assets Less Current Liabilities 1,809 12,793 Sharp decrease signals worsening financial position.
Net Assets (Shareholders Funds) 814 12,675 Drastic decline shows erosion of equity and reserves.
  • Working Capital: Negative in 2023, indicating the company may struggle to meet short-term obligations.
  • Equity/Earnings Reserves: Net assets have dropped by approximately 93.6%, eroding the company’s financial buffer.
  • Liquidity: Current assets are less than current liabilities, a key "vital sign" of strained cash flow and potential solvency concerns.

3. Diagnosis

ARTIVITY LTD is exhibiting clear symptoms of financial distress, primarily seen in its deteriorated liquidity position and sharply reduced net assets. The negative net current assets demonstrate that the company’s "cash flow health" is compromised, implying difficulties in covering short-term debts with available liquid resources.

The drop from £12,675 in net assets (equity) in 2022 to just £814 in 2023 suggests either operational losses, write-downs, or other non-recurring charges that have severely weakened the financial base. Although fixed assets have not dramatically decreased, the sharp fall in current assets indicates cash or receivable collection issues or inventory devaluation.

The consistent average employee number (6) suggests stable staffing, but the financial stress could undermine future operational capacity if not rectified.


4. Recommendations

  • Immediate Cash Flow Management:
    Prioritize improving liquidity by accelerating receivables, delaying non-essential payables, and reviewing inventory management to reduce working capital strain.

  • Cost Control and Profitability Review:
    Investigate causes of profits erosion. Tighten expenditure control and explore revenue enhancement strategies, especially given the company's focus on arts and cultural education sectors, which may have seasonal or pandemic-related demand fluctuations.

  • Financial Restructuring:
    Consider capital injection from the owner or external investors to rebuild equity and provide a cash buffer. Given the sole control by Elena Sandall, internal recapitalization is a potential pathway.

  • Debt Management:
    Engage with creditors to restructure short-term liabilities if cash shortages persist, possibly extending payment terms to alleviate immediate pressures.

  • Strategic Planning:
    Develop a robust business plan focusing on sustainable growth and resilience, including diversification or digital offerings in the arts and cultural education industry to boost revenues.

  • Regular Financial Monitoring:
    Implement monthly financial reviews focusing on liquidity ratios and working capital to detect and manage early warning signs of distress.


Medical Analogy Summary:

ARTIVITY LTD’s balance sheet reveals a company in "financial shock," with "vital signs" indicating liquidity failure (negative working capital) and "weakened immune system" (eroded equity). Without prompt intervention — akin to emergency treatment — the company risks "organ failure," i.e., insolvency or loss of business continuity.


Perspective: Financial Health Diagnostician · Model: gpt-4.1-mini · Generated 29 July 2025

Sign in to generate a free AI analysis of this company — no password needed, just an email link.